# RISE THERAPEUTICS, LLC: A Novel Immunological-Directed Live Biotherapy Product for Treating Crohn's Disease

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | RISE THERAPEUTICS, LLC |
| Location | Rockville, MD |
| Project | A Novel Immunological-Directed Live Biotherapy Product for Treating Crohn's Disease |
| Project number | 1R44DK146369-01 |
| Mechanism | R44 |
| Institute | National Institute of Diabetes and Digestive and Kidney Diseases |
| Award | $1,042,478 |
| Awarded | 2026-09-03 |
| Project period | 2026-09-01 to 2028-08-31 |
| UEI | N36JMJ1DKWH6 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11308837). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.